Allémann E - Search Results

1

Perivascular sustained release of atorvastatin from a hydrogel-microparticle delivery system decreases intimal hyperplasia.

Mylonaki I, Strano F, Deglise S, Allémann E, Alonso F, Corpataux JM, Dubuis C, Haefliger JA, Jordan O, Saucy F, Delie F. Mylonaki I, et al. Among authors: allemann e. J Control Release. 2016 Jun 28;232:93-102. doi: 10.1016/j.jconrel.2016.04.023. Epub 2016 Apr 16. J Control Release. 2016. PMID: 27091698

2

Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state.

De Jaeghere F, Allémann E, Kubel F, Galli B, Cozens R, Doelker E, Gurny R. De Jaeghere F, et al. Among authors: allemann e. J Control Release. 2000 Aug 10;68(2):291-8. doi: 10.1016/s0168-3659(00)00272-8. J Control Release. 2000. PMID: 10925137

3

Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles.

Delie F, Berton M, Allémann E, Gurny R. Delie F, et al. Among authors: allemann e. Int J Pharm. 2001 Feb 19;214(1-2):25-30. doi: 10.1016/s0378-5173(00)00627-x. Int J Pharm. 2001. PMID: 11282232

4

In vitro and in vivo activities of verteporfin-loaded nanoparticles.

Konan-Kouakou YN, Boch R, Gurny R, Allémann E. Konan-Kouakou YN, et al. Among authors: allemann e. J Control Release. 2005 Mar 2;103(1):83-91. doi: 10.1016/j.jconrel.2004.11.023. Epub 2005 Jan 11. J Control Release. 2005. PMID: 15710502

5

Pharmaceutical technology at the service of targeted drug delivery.

Allémann E, Delie F, Lange N. Allémann E, et al. Chimia (Aarau). 2012;66(5):308-12. doi: 10.2533/chimia.2012.308. Chimia (Aarau). 2012. PMID: 22867542 Free article. Review.

6

Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram.

Leyva-Gómez G, González-Trujano ME, López-Ruiz E, Couraud PO, Wekslerg B, Romero I, Miller F, Delie F, Allémann E, Quintanar-Guerrero D. Leyva-Gómez G, et al. Among authors: allemann e. J Pharm Sci. 2014 Aug;103(8):2509-19. doi: 10.1002/jps.24044. Epub 2014 Jun 10. J Pharm Sci. 2014. PMID: 24916334

7

Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system.

Pradal J, Zuluaga MF, Maudens P, Waldburger JM, Seemayer CA, Doelker E, Gabay C, Jordan O, Allémann E. Pradal J, et al. Among authors: allemann e. Eur J Pharm Biopharm. 2015 Jun;93:110-7. doi: 10.1016/j.ejpb.2015.03.017. Epub 2015 Mar 30. Eur J Pharm Biopharm. 2015. PMID: 25836052

8

Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice.

Pradal J, Maudens P, Gabay C, Seemayer CA, Jordan O, Allémann E. Pradal J, et al. Among authors: allemann e. Int J Pharm. 2016 Feb 10;498(1-2):119-29. doi: 10.1016/j.ijpharm.2015.12.015. Epub 2015 Dec 10. Int J Pharm. 2016. PMID: 26685724

9

Tunable phosphatase-sensitive stable prodrugs of 5-aminolevulinic acid for tumor fluorescence photodetection.

Babič A, Herceg V, Ateb I, Allémann E, Lange N. Babič A, et al. Among authors: allemann e. J Control Release. 2016 Aug 10;235:155-164. doi: 10.1016/j.jconrel.2016.05.047. Epub 2016 May 25. J Control Release. 2016. PMID: 27235981

10

Perivascular medical devices and drug delivery systems: Making the right choices.

Mylonaki I, Allémann É, Saucy F, Haefliger JA, Delie F, Jordan O. Mylonaki I, et al. Among authors: allemann e. Biomaterials. 2017 Jun;128:56-68. doi: 10.1016/j.biomaterials.2017.02.028. Epub 2017 Feb 28. Biomaterials. 2017. PMID: 28288349 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters